Cambridge Investment Research Advisors’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-67,113
| Closed | -$44K | – | 3548 |
|
|
2024
Q2 | $44K | Sell |
67,113
-16,969
| -20% | -$11.1K | ﹤0.01% | 3230 |
|
|
2024
Q1 | $51K | Sell |
84,082
-4,312
| -5% | -$2.62K | ﹤0.01% | 3212 |
|
|
2023
Q4 | $52K | Sell |
88,394
-5,162
| -6% | -$3.04K | ﹤0.01% | 3097 |
|
|
2023
Q3 | $62K | Sell |
93,556
-6,812
| -7% | -$4.51K | ﹤0.01% | 3019 |
|
|
2023
Q2 | $330K | Sell |
100,368
-7,035
| -7% | -$23.1K | ﹤0.01% | 2460 |
|
|
2023
Q1 | $976K | Sell |
107,403
-3,491
| -3% | -$31.7K | ﹤0.01% | 1593 |
|
|
2022
Q4 | $1.3M | Buy |
110,894
+6,476
| +6% | +$76K | 0.01% | 1341 |
|
|
2022
Q3 | $2.21M | Buy |
104,418
+29,980
| +40% | +$635K | 0.01% | 975 |
|
|
2022
Q2 | $1.81M | Buy |
74,438
+1,448
| +2% | +$35.1K | 0.01% | 1096 |
|
|
2022
Q1 | $3.64M | Buy |
72,990
+1,440
| +2% | +$71.7K | 0.02% | 802 |
|
|
2021
Q4 | $5.02M | Buy |
71,550
+2,685
| +4% | +$188K | 0.02% | 643 |
|
|
2021
Q3 | $6.43M | Buy |
68,865
+4,039
| +6% | +$377K | 0.03% | 505 |
|
|
2021
Q2 | $6.52M | Buy |
64,826
+5,831
| +10% | +$586K | 0.03% | 511 |
|
|
2021
Q1 | $5.5M | Buy |
58,995
+4,161
| +8% | +$388K | 0.03% | 526 |
|
|
2020
Q4 | $4.52M | Sell |
54,834
-6,344
| -10% | -$523K | 0.03% | 563 |
|
|
2020
Q3 | $5.25M | Buy |
61,178
+4,020
| +7% | +$345K | 0.04% | 447 |
|
|
2020
Q2 | $5.32M | Buy |
57,158
+172
| +0.3% | +$16K | 0.04% | 420 |
|
|
2020
Q1 | $1.62M | Sell |
56,986
-217
| -0.4% | -$6.18K | 0.02% | 752 |
|
|
2019
Q4 | $2.37M | Buy |
57,203
+3,031
| +6% | +$125K | 0.02% | 721 |
|
|
2019
Q3 | $766K | Buy |
54,172
+6,254
| +13% | +$88.4K | 0.01% | 1237 |
|
|
2019
Q2 | $1.68M | Buy |
47,918
+3,097
| +7% | +$109K | 0.02% | 788 |
|
|
2019
Q1 | $2.51M | Sell |
44,821
-16
| -0% | -$897 | 0.02% | 627 |
|
|
2018
Q4 | $2.15M | Sell |
44,837
-764
| -2% | -$36.7K | 0.02% | 610 |
|
|
2018
Q3 | $3.31M | Buy |
45,601
+2,219
| +5% | +$161K | 0.03% | 493 |
|
|
2018
Q2 | $3.58M | Sell |
43,382
-2,999
| -6% | -$247K | 0.04% | 436 |
|
|
2018
Q1 | $4.87M | Sell |
46,381
-1,036
| -2% | -$109K | 0.05% | 325 |
|
|
2017
Q4 | $6.07M | Buy |
47,417
+229
| +0.5% | +$29.3K | 0.07% | 268 |
|
|
2017
Q3 | $5.45M | Buy |
47,188
+1,255
| +3% | +$145K | 0.07% | 263 |
|
|
2017
Q2 | $5.99M | Buy |
45,933
+5
| +0% | +$652 | 0.09% | 214 |
|
|
2017
Q1 | $7.56M | Sell |
45,928
-218
| -0.5% | -$35.9K | 0.13% | 144 |
|
|
2016
Q4 | $4.29M | Buy |
46,146
+201
| +0.4% | +$18.7K | 0.08% | 234 |
|
|
2016
Q3 | $4.73M | Buy |
45,945
+11,255
| +32% | +$1.16M | 0.09% | 216 |
|
|
2016
Q2 | $4.11M | Sell |
34,690
-23,409
| -40% | -$2.77M | 0.09% | 216 |
|
|
2016
Q1 | $4.1M | Buy |
58,099
+10,329
| +22% | +$728K | 0.09% | 203 |
|
|
2015
Q4 | $3.5M | Buy |
+47,770
| New | +$3.5M | 0.08% | 239 |
|